Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mabpharm Limited (HK:2181)
HKEX:2181
Mabpharm Limited (2181) Stock Price & Analysis
0 Followers
2181 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$0.08 - HK$0.79
Previous CloseHK$0.37
Volume24.00K
Average Volume (3M)22.09K
Market Cap
HK$1.51B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Aug 23, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding4,124,080,000
10 Day Avg. Volume122,800
30 Day Avg. Volume22,095
Standard Deviation0.12
R-Squared0.22
Alpha0.00352
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mabpharm Limited News
PremiumCompany Announcements
Mabpharm Limited Announces Leadership Reshuffle
PremiumCompany Announcements
Mabpharm’s Core Drug CMAB008 Wins Approval in Peru
PremiumCompany Announcements
Mabpharm’s Core Cancer Drug Wins China Approval
PremiumCompany Announcements
Mabpharm Limited Unanimous Approval at AGM2181 FAQ
What was Mabpharm Limited’s price range in the past 12 months?
Mabpharm Limited lowest stock price was HK$0.08 and its highest was HK$0.79 in the past 12 months.
What is Mabpharm Limited’s market cap?
Currently, no data Available
When is Mabpharm Limited’s upcoming earnings report date?
Mabpharm Limited’s upcoming earnings report date is Aug 23, 2024 which is in 25 days.
How were Mabpharm Limited’s earnings last quarter?
Mabpharm Limited released its earnings results on Mar 26, 2024. The company reported -HK$0.029 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.029.
Is Mabpharm Limited overvalued?
According to Wall Street analysts Mabpharm Limited’s price is currently Overvalued.
Does Mabpharm Limited pay dividends?
Mabpharm Limited does not currently pay dividends.
What is Mabpharm Limited’s EPS estimate?
Mabpharm Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mabpharm Limited have?
Mabpharm Limited has 4,124,080,000 shares outstanding.
What happened to Mabpharm Limited’s price movement after its last earnings report?
Mabpharm Limited reported an EPS of -HK$0.029 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Mabpharm Limited?
Currently, no hedge funds are holding shares in HK:2181
---
Mabpharm Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.00%
12-Months-Change
Fundamentals
Return on Equity
-68.42%
Trailing 12-Months
Asset Growth
10.62%
Trailing 12-Months
Technical Analysis
ManpowerGroup Greater China Limited
―
Tian Chang Group Holdings Ltd.
―
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
―
---